Per- and poly-fluoroalkyl substances (PFAS) in pregnancy vascular and placental dysfunction
全氟烷基物质和多氟烷基物质 (PFAS) 与妊娠血管和胎盘功能障碍的关系
基本信息
- 批准号:10593111
- 负责人:
- 金额:$ 34.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-16 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectAgeAmino AcidsAngiogenesis InhibitorsAngiogenic FactorAnimalsAreaArteriesBiological MonitoringBlood PressureBlood VesselsBlood flowCardiovascular PhysiologyCell SeparationCellsChemicalsDeveloped CountriesDevelopmentDiameterDiseaseDoppler UltrasoundEconomic BurdenEndothelial CellsEndotheliumEnvironmental ExposureEpoprostenolEquilibriumEssential Fatty AcidsEtiologyExhibitsExposure toFailureFamilyFetal GrowthFetal Growth RetardationFetal healthFetusFunctional disorderFutureGlucoseGrowthHealthHumanHypertensionImpaired cognitionImpairmentIn VitroInterventionLengthLifeMeasuresMediatingMembrane PotentialsMesenteryMetabolicMetabolic syndromeModelingMolecular AnalysisMothersMyographyNational Institute of Environmental Health SciencesNatureNeurologicNewborn InfantNitratesNitritesNutrientOrganOutcomePathway interactionsPerfusionPerinatal CarePilot ProjectsPlacentaPoliciesPoly-fluoroalkyl substancesPotassium ChannelPregnancyPregnancy ComplicationsPregnant WomenProcessProductionPublic HealthRadioactive TracersRattusRelaxationResearch PriorityResistanceRiskRisk AssessmentRoleSignal PathwaySignal TransductionSpiral Artery of the EndometriumStructure of umbilical arterySystemSystemic blood pressureTelemetryTestingTimeTissuesToxic effectUterusVascular DiseasesVascular Endothelial Growth FactorsVascularizationVasodilationWaterWomanWorkangiogenesisbioaccumulationblood pressure elevationchannel blockersclinical careconsumer productendothelial dysfunctionenvironmental agentfatty acid transportfetalhemodynamicshigh riskhuman tissuein vivoknock-downmicroCTmother nutritionoffspringoverexpressionperfluorooctane sulfonateperinatal morbiditypregnantprogramsreproductivesextranslational studytrophoblast
项目摘要
ABSTRACT
Pregnancy-induced vascular adaptations, adequate placental vascularization, and optimal flux of nutrients
across the placenta to the fetus are critical to support fetal growth. Disruption in one or more of these
processes leads to fetal growth restriction (FGR). FGR affects up to 15% of all newborns, and no treatment is
available. The cause of FGR is not known, but the environmental exposure to per- and poly-fluoroalkyl
substances (PFAS) and its bioaccumulation in the placenta may hold important keys to understanding the
origins of the disease and the underlying causes of maternal organ dysfunction. Perfluorooctane sulfonate
(PFOS), a legacy PFAS, is the most produced and well studied PFAS. Elevated maternal PFOS is shown to be
associated with maternal vascular dysfunction and FGR in humans. Whether this increase in PFOS is directly
involved in endothelial dysfunction and manifestations of FGR is unknown. Our pilot studies show that elevated
PFOS in pregnant rats increases maternal blood pressure, blunts endothelial function, and decreases in
placental size, VEGF expression, and nutrient transport. Based on these findings, we hypothesize that
elevated PFOS levels impair maternal cardiovascular function and reduce placental vascularization and flux of
nutrients to lead to FGR. We will examine this premise in 3 aims employing in vivo animal studies, ex vivo
tissue-level functional analysis and in vitro molecular analyses. Aim 1 will first establish the functional effects of
elevated PFOS on systemic blood pressure and uterine artery blood flow and define the PFOS-mediated
signaling. To test the PFOS-mediated vascular mechanisms, EDHF, NO, and PGI2 relaxation pathways will be
determined. Also, the expression of eNOS and its activity state—signaling components of EDHF and PGI2
pathways as well as nitrate/nitrite and PGI2 production and changes in membrane potential—will be measured.
Then translational studies will test whether PFOS affects the endothelial pathways and mechanisms in
pregnant women by examining the effects in isolated omental and placental vessels. Aim 2 will examine
placental vascular effects. We will determine if elevated PFOS decreases growth, diameter, and length of
spiral arteries, central arterial canals, fetoplacental arterial branches, and umbilical arteries. We will also
measure the expression of pro- and anti-angiogenic factors in the placenta, and then determine if PFOS
disrupts signaling mechanisms in endothelial cells isolated from pregnant women. Aim 3 will examine placental
nutrient transport effects. We will determine if elevated PFOS decreases glucose, amino acid, and fatty acid
transport across the placenta to the fetus and measure the expression of nutrient transporters in the placenta.
Then, determine if PFOS disrupts nutrient transport in pregnant women by examining the effects in primary
trophoblasts. These results are expected to have an important impact because they will contribute
substantively to a mechanism-based understanding of PFOS's role in pregnancy complications and alert
environmental agencies to devise policies to curtail PFOS exposure to reproductive-age women.
摘要
妊娠诱导的血管适应、充足的胎盘血管化和最佳的营养素流量
通过胎盘到达胎儿对支持胎儿生长至关重要。其中一个或多个中断
胎儿生长受限(FGR)。FGR影响高达15%的所有新生儿,没有治疗方法是
available. FGR的原因尚不清楚,但环境暴露于全氟烷基和多氟烷基
PFAS及其在胎盘中的生物积累可能是了解
疾病的起源和母体器官功能障碍的根本原因。全氟辛烷磺酸
全氟辛烷磺酸(PFOS)是一种传统的全氟辛烷磺酸,是生产最多、研究最充分的全氟辛烷磺酸。母体全氟辛烷磺酸浓度升高,
与人类母体血管功能障碍和FGR相关。全氟辛烷磺酸的增加是否直接
参与内皮功能障碍和FGR的表现是未知的。我们的初步研究表明,
孕鼠体内的全氟辛烷磺酸会增加母体血压,削弱内皮功能,
胎盘大小、VEGF表达和营养转运。基于这些发现,我们假设,
全氟辛烷磺酸水平升高会损害母体心血管功能,减少胎盘血管形成和血流量,
导致FGR的营养素。我们将在3个目标中采用体内动物研究、离体动物研究和体外动物研究来研究这一前提。
组织水平的功能分析和体外分子分析。目标1将首先确定
全氟辛烷磺酸对全身血压和子宫动脉血流的影响,并确定全氟辛烷磺酸介导的
信号为了测试PFOS介导的血管机制,将研究EDHF、NO和PGI 2舒张途径。
测定此外,eNOS的表达及其活性状态--EDHF和PGI 2的信号成分,
途径以及硝酸盐/亚硝酸盐和PGI 2的生产和膜电位的变化将被测量。
然后,转化研究将测试全氟辛烷磺酸是否会影响内皮细胞的途径和机制,
通过检查离体网膜和胎盘血管的影响,对孕妇进行了研究。目标2将检查
胎盘血管效应我们将确定PFOS浓度升高是否会降低植物的生长、直径和长度,
螺旋动脉、中央动脉管、胎儿胎盘动脉分支和脐动脉。我们还将
测量胎盘中促血管生成因子和抗血管生成因子的表达,
破坏从孕妇分离的内皮细胞中的信号传导机制。目的3将检查胎盘
养分运输效应。我们将确定全氟辛烷磺酸浓度升高是否会降低葡萄糖、氨基酸和脂肪酸
通过胎盘运输到胎儿,并测量胎盘中营养转运蛋白的表达。
然后,通过检查全氟辛烷磺酸对孕妇的影响,确定全氟辛烷磺酸是否会干扰孕妇的营养转运。
滋养层这些成果预计将产生重要影响,因为它们将有助于
对全氟辛烷磺酸在妊娠并发症中的作用有实质性的了解,
环境机构制定政策,减少育龄妇女接触全氟辛烷磺酸。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SATHISH KUMAR其他文献
SATHISH KUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SATHISH KUMAR', 18)}}的其他基金
Per- and poly-fluoroalkyl substances (PFAS) in pregnancy vascular and placental dysfunction
全氟烷基物质和多氟烷基物质 (PFAS) 与妊娠血管和胎盘功能障碍的关系
- 批准号:
10452310 - 财政年份:2022
- 资助金额:
$ 34.39万 - 项目类别:
Vascular AT2R expression and function during pregnancy
妊娠期间血管AT2R的表达和功能
- 批准号:
9981801 - 财政年份:2017
- 资助金额:
$ 34.39万 - 项目类别:
Sex-specific fetal programming of adult vascular dysfunction and hypertension
成人血管功能障碍和高血压的性别特异性胎儿编程
- 批准号:
9493232 - 财政年份:2013
- 资助金额:
$ 34.39万 - 项目类别:
Sex-specific fetal programming of adult vascular dysfunction and hypertension
成人血管功能障碍和高血压的性别特异性胎儿编程
- 批准号:
8853942 - 财政年份:2013
- 资助金额:
$ 34.39万 - 项目类别:
Sex-specific fetal programming of adult vascular dysfunction and hypertension
成人血管功能障碍和高血压的性别特异性胎儿编程
- 批准号:
8561661 - 财政年份:2013
- 资助金额:
$ 34.39万 - 项目类别:
Sex-specific fetal programming of adult vascular dysfunction and hypertension
成人血管功能障碍和高血压的性别特异性胎儿编程
- 批准号:
8719169 - 财政年份:2013
- 资助金额:
$ 34.39万 - 项目类别:
Maternal Androgen Excess: Vascular and Placental Function and Fetal Consequences
母体雄激素过多:血管和胎盘功能以及胎儿的后果
- 批准号:
8306815 - 财政年份:2011
- 资助金额:
$ 34.39万 - 项目类别:
Maternal Androgen Excess: Vascular and Placental Function and Fetal Consequences
母体雄激素过多:血管和胎盘功能以及胎儿的后果
- 批准号:
8177474 - 财政年份:2011
- 资助金额:
$ 34.39万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 34.39万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 34.39万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 34.39万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 34.39万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 34.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 34.39万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 34.39万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 34.39万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 34.39万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 34.39万 - 项目类别:
Miscellaneous Programs